Michael Zhen-Yu Tong

Michael Zhen-Yu Tong

Auto-generated profile, based on publicly available information

Michael Zhen-Yu Tong

Department of Thoracic and Cardiovascular Surgery, Miller Family Heart, Vascular & Thoracic Institute, Cleveland Clinic, Cleveland, OH 44195, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2019 in ESC Heart Failure
Verified
Journal Article
Open access
PDF file
KVKenneth Varian
Kenneth Varian
WXWeining David Xu
Weining David Xu
WLWeiqin Lin
Weiqin Lin
SUShinya Unai
Shinya Unai
MTMichael Z. Tong
Michael Z. Tong
APAntonio L. Perez
Antonio L. Perez
Cardiogenic shock from biventricular failure that requires acute mechanical circulatory support carries high 30 day mortality. Acute mechanical circulatory support can serve as bridge to orthotopic heart transplant (OHT) in selected patients. We report a patient with biventricular failure secondary to rapidly progressive cardiac sarcoidosis refractory to medical management who was bridged to OHT with Impella 5.0 and Impella RP—temporary left and right ventricular assist devices, respectively. This is the first successful bridge to transplantation using these devices in biventricular heart failure and cardiogenic shock. We discuss considerations for using this strategy over veno-arterial extracorporeal membrane oxygenation or surgically implanted assist devices in patients with cardiogenic shock and biventricular failure as a bridge to OHT.

1 May 2021 in The Annals of Thoracic Surgery
Verified
Journal Article
Open access
VSVikram Sharma
Vikram Sharma
KCKevin Chen
Kevin Chen
SAShehab A.R. Alansari
Shehab A.R. Alansari
BVBeni Verma
Beni Verma
ESEdward G. Soltesz
Edward G. Soltesz
FBFaisal G. Bakaeen
Faisal G. Bakaeen
Early coronary ischemic events are uncommon after cardiac surgery, with little known about their management or associated outcomes. We evaluated clinical outcomes of patients undergoing coronary angiography ± percutaneous coronary intervention or redo coronary artery bypass grafting for suspected coronary ischemia within 3 weeks after index cardiac surgery. This is a retrospective observational study based on data from 53,287 patients who underwent cardiac surgery at our institution (1996-2017); 180 patients (0.34%) satisfied the inclusion criteria. The primary outcome was 1-year all-cause mortality. Statistical evaluation involved χ2, analysis of variance, Kaplan-Meier, and receiver operating characteristic curve analyses. Most coronary angiography ± percutaneous coronary intervention and redo coronary artery bypass grafting procedures occurred in the first 2 weeks after index cardiac surgery. Patients presenting with ST elevation myocardial infarction (STEMI)/non-STEMI had the lowest 1-year mortality (13.5%), followed by patients with ventricular tachycardia/fibrillation (28.1%), and patients with non-ventricular tachycardia/fibrillation arrest or hemodynamic instability alone the worst (38.6%) (χ2 = 17.3, P = .001). Peak troponin T level after cardiac surgery was strongly predictive of 1-year mortality (area under the curve, 0.74; 95% confidence interval, 0.65-0.84; P < .001) but did not predict the presence of coronary compromise. For acute graft failure, 1-year mortality was better with percutaneous coronary intervention (18.2%) than redo coronary artery bypass grafting (23.5%) or no indicated/feasible intervention (29.2%). Although suspected myocardial ischemia requiring coronary angiography or intervention early after cardiac surgery was rare, mortality was high, particularly in presentations other than STEMI/non-STEMI. In patients with overt signs and symptoms of myocardial ischemia after index cardiac surgery, troponin T was not a reliable marker of underlying coronary or graft obstruction but was a robust predictor of 1-year mortality.

12 October 2023 in Structural Heart
Verified
Journal Article
Open access
VPViral Patel
Viral Patel
SUShinya Unai
Shinya Unai
RMRyan Moore
Ryan Moore
HLHabib Layoun
Habib Layoun
SHSerge Harb
Serge Harb
GPGösta B. Pettersson
Gösta B. Pettersson
The Ozaki procedure using autologous pericardium is an interesting but complex alternative for aortic valve replacement. We present a standardized approach to minimize the learning curve and confirm reproducibility. After careful preparation, from May 2015 to February 2021, an Ozaki procedure was performed on 46 patients age 51 ± 14 years. Seven had unicuspid (15%), 29 bicuspid (63%), and 10 tricuspid (22%) aortic valves, and 2 patients had endocarditis. Endpoints were operative learning curves, perioperative outcomes, intermediate-term valve hemodynamics, reintervention, health-related quality of life (MacNew Heart Disease Health-Related Quality of Life questionnaire), and mortality. Cardiopulmonary bypass and aortic clamp times decreased from 145 to 125 ​minutes and 120 to 100 ​minutes, respectively, over the first 20 cases, reflecting the learning curve. There was no major perioperative morbidity or mortality. Median postoperative stay was 6.9 days. Aortic regurgitation was mild or less in all but 2 patients who developed moderate aortic regurgitation. Mean aortic valve gradient was 7.9 mmHg postoperatively, 9.2 mmHg by 6 months, and constant thereafter. Left ventricular ejection fraction was 58% preoperatively, 60% at 6 months, and remained stable thereafter. One patient developed infective endocarditis 7 months postoperatively, failed medical management, and underwent valve replacement at 14 months. Two-year survival was 96%, with 1 noncardiac death at 16 months. Health-related quality of life in mental, physical, and emotional domains was better than matched norms, global 6.2 vs. 5.0 (p < 0.0001). Using a well-prepared standardized approach, the Ozaki procedure is reproducible with a short learning curve, excellent hemodynamic performance, and good quality of life.

1 April 2021 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Open access
VRV.K. Randhawa
V.K. Randhawa
RLR. Lee
R. Lee
LIL. Ives
L. Ives
ESE.G. Soltesz
E.G. Soltesz
MTM.Z. Tong
M.Z. Tong
JEJ.D. Estep
J.D. Estep

22 January 2026 in The Heart Surgery Forum
Verified
Journal Article
Open access
AAAhmed K. Awad
Ahmed K. Awad
SASharma Abhishek
Sharma Abhishek
ATAndrew Tang
Andrew Tang
MAMahmoud Alshneikat
Mahmoud Alshneikat
MKMarijan J. Koprivanac
Marijan J. Koprivanac
FBFaisal G. Bakaeen
Faisal G. Bakaeen
Coronary artery bypass grafting (CABG) is the most frequently performed cardiac surgery worldwide. Improvements in operative technique and perioperative care have led to a significant reduction in associated morbidity and mortality. Achieving optimal outcomes requires meticulous surgical technique that is complemented by comprehensive postoperative care. This review aims to summarize the principles of postoperative care following CABG based on latest evidence and our extensive institutional experience. Immediate postoperative care in the intensive care unit focuses on management of acute cardiorespiratory issues, bleeding, and pain management. Ward care focuses of ensuring a smooth transition from inpatient treatment to outpatient recovery. Protocolized postoperative interventions, including Enhanced Recovery after Surgery-cardiac and emerging applications of automation and artificial intelligence, are transforming postoperative CABG care by promoting faster recovery, reducing complications, and enabling more personalized, data-driven decision-making.

2 February 2022 in Journal of Cardiac Failure
Verified
Journal Article
Closed access
JHJared J. Herr
Jared J. Herr
MTMichael Tong
Michael Tong
BDBenjamin D'SOuza
Benjamin D'SOuza
FSFarooq Sheikh
Farooq Sheikh
ALAnuradha Lala
Anuradha Lala
ARAshwin Ravichandran
Ashwin Ravichandran